story of the week
Quality of Life in Women With Early-Stage and Metastatic HR+/HER2− Breast Cancer Receiving Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy
Oncologist 2024 Jun 21;[EPub Ahead of Print], D O'Reilly, AR Farooq, P Nevins Selvadurai, L Sheehan, K Molan, B Krishnanivas, V Mullen, D McMahon, D Hadi, A Ahmed, M Jennings, H Carroll, S Chew, B Macanovic, C O'Hanlon Brown, SA Noonan, S O Reilly, RM Connolly, C Cahir, CM KellyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.